Source: RQM+ Blog

RQM+ Blog We Make Women's Health Happen: Innovative Devices for Fertility Treatment

Navigating fertility treatments can be a physically and emotionally demanding experience for women. As the sole child bearers, women are more directly impacted by procedures like in vitro fertilization (IVF), which require a significant toll on their bodies even before pregnancy begins. The initial stages often involve 2-4 weeks of fertility hormone treatments, frequently administered through multiple self-injections. Recognizing the stress associated with this process, RQM+ is dedicated to helping bring innovative solutions to market that can ease this burden.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
John Potthoff's photo - CEO of RQM+

CEO

John Potthoff

CEO Approval Rating

82/100

Read more